Bioinformatics analysis of proteomic profiles during the process of anti-Thy1 nephritis

Molecular and Cellular Proteomics

Volumn 11, Issue 4, 2012, Pages

  Lu, Yang ^a   Liu, Xiaoluan ^a,b   Shi, Suozhu ^a   Su, Huabin ^a   Bai, Xueyuan ^a   Cai, Guangyan ^a   Yang, Fuquan ^c   Xie, Zhensheng ^c   Zhu, Yunping ^d   Zhang, Yanqiong ^d   Zhang, Shujia ^a   Li, Xiaofan ^a   Wang, Shan ^a   Wu, Di ^a   Zhang, Li ^a   Wu, Jie ^a   Xie, Yuansheng ^a   Chen, Xiangmei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b NANKAI UNIVERSITY   (China)

^c INSTITUTE OF BIOPHYSICS   (China)

^d Beijing Proteome Research Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; DIFFERENTIALLY EXPRESSED PROTEIN; PEPTIDES AND PROTEINS; PROTEIN AGAT; PROTEIN AKR1A1; PROTEIN ATP6V1B2; PROTEIN FHL2; PROTEIN HIBADH; PROTEIN MDH1; PROTEIN MPST; PROTEIN NIT2; PROTEIN PRDX6; PROTEIN PSMB7; PROTEIN TPI1; UNCLASSIFIED DRUG; ALLOANTIBODY; ANTI THY ANTIBODY; ANTI-THY ANTIBODY; FHL2 PROTEIN, RAT; LIM HOMEODOMAIN PROTEIN; MUSCLE PROTEIN; PROTEIN; TRANSCRIPTION FACTOR;

ACTIN FILAMENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTI THY1 NEPHRITIS; APOPTOSIS; ARTICLE; BIOINFORMATICS; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CELL TRANSPORT; ENERGY METABOLISM; GEL ELECTROPHORESIS; GLOMERULUS; IMMUNOHISTOCHEMISTRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MESANGIUM; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RAT; TWO DIMENSIONAL FLUORESCENCE DIFFERENCE GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING; ANIMAL; CLUSTER ANALYSIS; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; MALE; MESANGIUM CELL; METABOLISM; PATHOLOGY; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; WISTAR RAT;

ANIMALS; CELL PROLIFERATION; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; ISOANTIBODIES; LIM-HOMEODOMAIN PROTEINS; MALE; MESANGIAL CELLS; MUSCLE PROTEINS; NEPHRITIS; PROTEINS; PROTEOMICS; RATS; RATS, WISTAR; TRANSCRIPTION FACTORS; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

EID: 84859834949     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.008755     Document Type: Article

References (41)

1. Jefferson, J. A., and Johnson, R. J. (1999) Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1.1 model). J. Nephrol. 12, 297-307 (Pubitemid 30014640)
2. Inagi, R., Kumagai, T., Nishi, H., Kawakami, T., Miyata, T., Fujita, T., and Nangaku, M. (2008) Preconditioning with endoplasmic reticulum stress ameliorates mesangioproliferative glomerulonephritis. J Am. Soc. Nephrol. 19, 915-922
3. Kumar, D., Bhaskaran, M., Alagappan, L., Tori, D., Yadav, I., Konkimalla, S., Magoon, S., and Singhal, P. C. (2010) Heme oxygenase-1 modulates mesangial cell proliferation by p21 Waf1 upregulation. Ren. Fail. 32, 254-258
4. Hartner, A., Hilgers, K. F., Bitzer, M., Veelken, R., and Schöcklmann, H. O. (2003) Dynamic expression patterns of transforming growth factorbeta (2) and transforming growth factor-beta receptors in experimental glomerulonephritis. J. Mol. Med. 81, 32-42 (Pubitemid 36207881)
5. Jyo-Oshiro, Y., Sasaki, T., Kawakami, Y., Nohno, T., Itoh, N., Osawa, G., and Kashihara, N. (1999) Expression of the fibroblast growth factor receptor 1-4 genes in glomeruli in anti-Thy1.1 mesangial proliferative glomerulonephritis. Virchows Arch. 435, 501-508
6. Sasaki, S., Bao, Q., and Hughes, R. C. (1999) Galectin-3 modulates rat mesangial cell proliferation and matrix synthesis during experimental glomerulonephritis induced by anti-Thy1.1 antibodies. J Pathol 187, 481-489 (Pubitemid 29118282)
7. Bokemeyer, D., Ostendorf, T., Kunter, U., Lindemann, M., Kramer, H. J., and Floege, J. (2000) Differential activation of mitogen-activated protein kinases in experimental mesangioproliferative glomerulonephritis. J. Am. Soc. Nephrol. 11, 232-240 (Pubitemid 30064846)
8. Shimizu, A., Kitamura, H., Masuda, Y., Ishizaki, M., Sugisaki, Y., and Yamanaka, N. (1995) Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int. 47, 114-121
9. Porst, M., Plank, C., Bieritz, B., Konik, E., Fees, H., Dötsch, J., Hilgers, K. F., Reinhardt, D. P., and Hartner, A. (2006) Fibrillin-1 regulates mesangial cell attachment, spreading, migration and proliferation. Kidney Int. 69, 450-456 (Pubitemid 43164435)
10. Nazeer, K., Janech, M. G., Lin, J. J., Ryan, K. J., Arthur, J. M., and Budisavljevic, M. N. (2009) Changes in protein profiles during course of experimental glomerulonephritis. Am. J. Physiol. Renal Physiol 296, F186-193
11. Amann, T., Egle, Y., Bosserhoff, A. K., and Hellerbrand, C. (2010) FHL2 suppresses growth and differentiation of the colon cancer cell line HT-29. Oncol. Rep. 23, 1669-1674
12. Ding, L., Wang, Z., Yan, J., Yang, X., Liu, A., Qiu, W., Zhu, J., Han, J., Zhang, H., Lin, J., Cheng, L., Qin, X., Niu, C., Yuan, B., Wang, X., Zhu, C., Zhou, Y., Li, J., Song, H., Huang, C., and Ye, Q. (2009) Human four-and-a-half LIM family members suppress tumor cell growth through a TGFbeta- like signaling pathway. J. Clin. Invest. 119, 349-361
13. Labalette, C., Nouët, Y., Sobczak-Thepot, J., Armengol, C., Levillayer, F., Gendron, M. C., Renard, C. A., Regnault, B., Chen, J., Buendia, M. A., and Wei, Y. (2008) The LIM-only protein FHL2 regulates cyclin D1 expression and cell proliferation. J. Biol. Chem. 283, 15201-15208
14. Li, M., Wang, J., Ng, S. S., Chan, C. Y., Chen, A. C., Xia, H. P., Yew, D. T., Wong, B. C., Chen, Z., Kung, H. F., and Lin, M. C. (2008) The four-and-a-half-LIM protein 2 (FHL2) is overexpressed in gliomas and associated with oncogenic activities. Glia 56, 1328-1338
15. Paul, R. V., Wackym, P. S., and Budisavljevic, M. N. (1998) Destabilization of natriuretic peptide C-receptor mRNA by phorbol myristate acetate. J. Am. Soc. Nephrol. 9, 26-32 (Pubitemid 28050040)
16. Johnson, R. J., Garcia, R. L., Pritzl, P., and Alpers, C. E. (1990) Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am. J. Pathol. 136, 369-374 (Pubitemid 20074611)
17. Li, Z., Chen, X., Xie, Y., Shi, S., Feng, Z., Fu, B., Zhang, X., Cai, G., Wu, C., Wu, D., and Gu, Y. (2004) Expression and significance of integrin-linked kinase in cultured cells, normal tissue, and diseased tissue of aging rat kidneys. J. Gerontol. A Biol. Sci. Med. Sci. 59, 984-996 (Pubitemid 39441787)
18. Sun, J., Yan, G., Ren, A., You, B., and Liao, J. K. (2006) FHL2/SLIM3 decreases cardiomyocyte survival by inhibitory interaction with sphingosine kinase-1. Circ. Res. 99, 468-476 (Pubitemid 44337818)
19. Perluigi, M., Sultana, R., Cenini, G., Di Domenico, F., Memo, M., Pierce, W. M., Coccia, R., and Butterfield, D. A. (2009) Redox proteomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis. Proteomics Clin. Appl. 3, 682-693
20. Nilo, R., Saffie, C., Lilley, K., Baeza-Yates, R., Cambiazo, V., Campos- Vargas, R., González, M., Meisel, L. A., Retamales, J., Silva, H., and Orellana, A. (2010) Proteomic analysis of peach fruit mesocarp softening and chilling injury using difference gel electrophoresis (DIGE). BMC Genomics 11, 43
21. Antalis, C. J., Arnold, T., Rasool, T., Lee, B., Buhman, K. K., and Siddiqui, R. A. (2010) High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation. Breast Cancer Res. Treat. 122, 661-670
22. Su, Y. R., Dove, D. E., Major, A. S., Hasty, A. H., Boone, B., Linton, M. F., and Fazio, S. (2005) Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in apolipoprotein E-deficient mice lacking macrophage-derived ACAT1. Circulation 111, 2373-2381 (Pubitemid 40647073)
23. Liu, X., Feng, R., and Du, L. (2010) The role of enoyl-CoA hydratase short chain 1 and peroxiredoxin 3 in PP2-induced apoptosis in human breast cancer MCF-7 cells. FEBS Lett. 584, 3185-3192
24. Zhang, X., Yang, J., Guo, Y., Ye, H., Yu, C., Xu, C., Xu, L., Wu, S., Sun, W., Wei, H., Gao, X., Zhu, Y., Qian, X., Jiang, Y., Li, Y., and He, F. (2010) Functional proteomic analysis of nonalcoholic fatty liver disease in rat models: enoyl-coenzyme a hydratase down-regulation exacerbates hepatic steatosis. Hepatology 51, 1190-1199
25. Supino, R., Scovassi, A. I., Croce, A. C., Dal Bo, L., Favini, E., Corbelli, A., Farina, C., Misiano, P., and Zunino, F. (2009) Biological effects of a new vacuolar-H,-ATPase inhibitor in colon carcinoma cell lines. Ann. N.Y. Acad. Sci. 1171, 606-616
26. Sasazawa, Y., Futamura, Y., Tashiro, E., and Imoto, M. (2009) Vacuolar H+-ATPase inhibitors overcome Bcl-xL-mediated chemoresistance through restoration of a caspase-independent apoptotic pathway. Cancer Sci. 100, 1460-1467
27. Cox, A. G., Brown, K. K., Arner, E. S., and Hampton, M. B. (2008) The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation. Biochem. Pharmacol. 76, 1097-1109
28. Nonn, L., Berggren, M., and Powis, G. (2003) Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis. Mol. Cancer Res. 1, 682-689 (Pubitemid 36870521)
29. Walsh, B., Pearl, A., Suchy, S., Tartaglio, J., Visco, K., and Phelan, S. A. (2009) Overexpression of Prdx6 and resistance to peroxide-induced death in Hepa1-6 cells: Prdx suppression increases apoptosis. Redox. Rep. 14, 275-284
30. Chang, X. Z., Li, D. Q., Hou, Y. F., Wu, J., Lu, J. S., Di, G. H., Jin, W., Ou, Z. L., Shen, Z. Z., and Shao, Z. M. (2007) Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res. 9, R76
31. Jackman, S. A., Hough, D. W., Danson, M. J., Stevenson, K. J., and Opperdoes, F. R. (1990) Subcellular localisation of dihydrolipoamide dehydrogenase and detection of lipoic acid in bloodstream forms of Trypanosoma brucei. Eur. J. Biochem. 193, 91-95 (Pubitemid 20331614)
32. Ahlborn, G. J., Delker, D. A., Roop, B. C., Geter, D. R., Allen, J. W., Deangelo, A. B., and Winnik, W. M. (2009) Early Alterations in Protein and Gene Expression in Rat Kidney Following Bromate Exposure. Food Chem. Toxicol. 47, 1154-1160
33. Barron-Casella, E. A., Torres, M. A., Scherer, S. W., Heng, H. H., Tsui, L. C., and Casella, J. F. (1995) Sequence analysis and chromosomal localization of human Cap Z. Conserved residues within the actin-binding domain may link Cap Z to gelsolin/severin and profilin protein families. J. Biol. Chem. 270, 21472-21479
34. Schmidt, K., and Nichols, B. J. (2004) Functional interdependence between septin and actin cytoskeleton. BMC Cell Biol. 5, 43
35. Canault, M., Tellier, E., Bonardo, B., Mas, E., Aumailley, M., Juhan-Vague, I., Nalbone, G., and Peiretti, F. (2006) FHL2 interacts with both ADAM-17 and the cytoskeleton and regulates ADAM-17 localization and activity. J. Cell. Physiol. 208, 363-372 (Pubitemid 43993427)
36. Ohno, K., Kato, H., Funahashi, S., Hasegawa, T., and Sato, K. (2009) Characterization of CLP36/Elfin/PDLIM1 in the nervous system. J. Neurochem. 111, 790-800
37. Martin, B. T., Kleiber, K., Wixler, V., Raab, M., Zimmer, B., Kaufmann, M., and Strebhardt, K. (2007) FHL2 regulates cell cycle-dependent and doxorubicin-induced p21Cip1/Waf1 expression in breast cancer cells. Cell Cycle 6, 1779-1788 (Pubitemid 47327932)
38. Paul, C., Lacroix, M., Iankova, I., Julien, E., Schäfer, B. W., Labalette, C., Wei, Y., Le Cam, A., Le Cam, L., and Sardet, C. (2006) The LIM-only protein FHL2 is a negative regulator of E4F1. Oncogene 25, 5475-5484 (Pubitemid 44344098)
39. Ng, C. F., Ng, P. K., Lui, V. W., Li, J., Chan, J. Y., Fung, K. P., Ng, Y. K., Lai, P. B., and Tsui, S. K. (2011) FHL2 exhibits anti-proliferative and antiapoptotic activities in liver cancer cells. Cancer Lett. 304, 97-106
40. Han, W., Wu, Z., Zhao, Y., Meng, Y., Si, Y., Yang, J., Fu, X., and Yu, L. (2009) FHL2 interacts with and acts as a functional repressor of Id2 in human neuroblastoma cells. Nucleic Acids Res. 37, 3996-4009
41. Bokemeyer, D., Guglielmi, K. E., McGinty, A., Sorokin, A., Lianos, E. A., and Dunn, M. J. (1998) Different activation of mitogen-activated protein kinases in experimental proliferative glomerulonephritis. Kidney Int. Suppl. 67, S189-191 (Pubitemid 28405713)